Skip to main content

Table 7 Complications and outcomes

From: Clinical and epidemiologic characterization of patients with systemic lupus erythematosus admitted to an intensive care unit in Colombia

Complications n/N (%)
Infections 29/45 (64,4)
 • Nosocomial 20/29 (69,0)
  o Pneumonia 12/20 (60,0)
  o Urinary tract infection 7/20 (35,0)
  o Bacteriemia 7/20 (35,0)
  o Soft tissue 2/20 (10,0)
  o Intrabdominal 1/20 (5,0)
 • Acquired in the community 7/29 (24,1)
  o Urinary tract infection 3/7 (42,9)
  o Pneumonia 2/7 (28,6)
  o Bacteriemia 2/7 (28,6)
  o Soft tissue 1/7 (14,3)
  o Intrabdominal 1/7 (14,3)
 • Nosocomial and acquiered in community 2/29 (6,9)
Acute kidney injury 24/45 (53,3)
Re-admissions to ICU 7/45 (21,2)
Death 4/33 (12,1)
  1. Boldface is the values with stadistic signficance p < 0.05